Literature DB >> 24413774

STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling.

Andreas Begitt1, Mathias Droescher2, Thomas Meyer3, Christoph D Schmid4, Michelle Baker5, Filipa Antunes1, Klaus-Peter Knobeloch, Markus R Owen5, Ronald Naumann6, Thomas Decker7, Uwe Vinkemeier8.   

Abstract

STAT1 is an indispensable component of a heterotrimer (ISGF3) and a STAT1 homodimer (GAF) that function as transcription regulators in type 1 and type 2 interferon signaling, respectively. To investigate the importance of STAT1-cooperative DNA binding, we generated gene-targeted mice expressing cooperativity-deficient STAT1 with alanine substituted for Phe77. Neither ISGF3 nor GAF bound DNA cooperatively in the STAT1F77A mouse strain, but type 1 and type 2 interferon responses were affected differently. Type 2 interferon-mediated transcription and antibacterial immunity essentially disappeared owing to defective promoter recruitment of GAF. In contrast, STAT1 recruitment to ISGF3 binding sites and type 1 interferon-dependent responses, including antiviral protection, remained intact. We conclude that STAT1 cooperativity is essential for its biological activity and underlies the cellular responses to type 2, but not type 1 interferon.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24413774     DOI: 10.1038/ni.2794

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  50 in total

1.  DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1.

Authors:  Thomas Meyer; Andreas Marg; Petra Lemke; Burkhard Wiesner; Uwe Vinkemeier
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

2.  Bicoid cooperative DNA binding is critical for embryonic patterning in Drosophila.

Authors:  Danielle Lebrecht; Marisa Foehr; Eric Smith; Francisco J P Lopes; Carlos E Vanario-Alonso; John Reinitz; David S Burz; Steven D Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

Review 3.  How cells respond to interferons.

Authors:  G R Stark; I M Kerr; B R Williams; R H Silverman; R D Schreiber
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  STAT1 signaling is not regulated by a phosphorylation-acetylation switch.

Authors:  Filipa Antunes; Andreas Marg; Uwe Vinkemeier
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

5.  Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA.

Authors:  H A Bluyssen; D E Levy
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

Review 6.  The JAK-STAT pathway at twenty.

Authors:  George R Stark; James E Darnell
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

7.  Global changes in STAT target selection and transcription regulation upon interferon treatments.

Authors:  Stephen E Hartman; Paul Bertone; Anjali K Nath; Thomas E Royce; Mark Gerstein; Sherman Weissman; Michael Snyder
Journal:  Genes Dev       Date:  2005-11-30       Impact factor: 11.361

8.  Green fluorescent protein-tagging reduces the nucleocytoplasmic shuttling specifically of unphosphorylated STAT1.

Authors:  Thomas Meyer; Andreas Begitt; Uwe Vinkemeier
Journal:  FEBS J       Date:  2007-02       Impact factor: 5.542

9.  Alternative activation of STAT1 and STAT3 in response to interferon-gamma.

Authors:  Yulan Qing; George R Stark
Journal:  J Biol Chem       Date:  2004-07-27       Impact factor: 5.157

10.  Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations.

Authors:  Nikola Wenta; Holger Strauss; Stefanie Meyer; Uwe Vinkemeier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

View more
  36 in total

1.  Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity.

Authors:  Tiancen Hu; Jennifer E Yeh; Luca Pinello; Jaison Jacob; Srinivas Chakravarthy; Guo-Cheng Yuan; Rajiv Chopra; David A Frank
Journal:  Mol Cell Biol       Date:  2015-07-13       Impact factor: 4.272

Review 2.  IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.

Authors:  Lionel B Ivashkiv
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 53.106

3.  Interferon-α signaling promotes embryonic HSC maturation.

Authors:  Peter Geon Kim; Matthew C Canver; Catherine Rhee; Samantha J Ross; June V Harriss; Ho-Chou Tu; Stuart H Orkin; Haley O Tucker; George Q Daley
Journal:  Blood       Date:  2016-04-19       Impact factor: 22.113

4.  BET bromodomain inhibition suppresses transcriptional responses to cytokine-Jak-STAT signaling in a gene-specific manner in human monocytes.

Authors:  Chun Hin Chan; Celestia Fang; Anna Yarilina; Rab K Prinjha; Yu Qiao; Lionel B Ivashkiv
Journal:  Eur J Immunol       Date:  2014-12-01       Impact factor: 5.532

5.  The Effect of SH2B1 Variants on Expression of Leptin- and Insulin-Induced Pathways in Murine Hypothalamus.

Authors:  Johanna Giuranna; Anna-Lena Volckmar; Anna Heinen; Triinu Peters; Börge Schmidt; Anne Spieker; Helena Straub; Harald Grallert; Timo D Müller; Jochen Antel; Ute Haußmann; Hans Klafki; Liangyou Rui; Johannes Hebebrand; Anke Hinney
Journal:  Obes Facts       Date:  2018-04-10       Impact factor: 3.942

6.  Nipah and Hendra Virus Nucleoproteins Inhibit Nuclear Accumulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT2 by Interfering with Their Complex Formation.

Authors:  Akihiro Sugai; Hiroki Sato; Ikuyo Takayama; Misako Yoneda; Chieko Kai
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

7.  STAT1β is not dominant negative and is capable of contributing to gamma interferon-dependent innate immunity.

Authors:  Christian Semper; Nicole R Leitner; Caroline Lassnig; Matthias Parrini; Tanel Mahlakõiv; Michael Rammerstorfer; Karin Lorenz; Doris Rigler; Simone Müller; Thomas Kolbe; Claus Vogl; Thomas Rülicke; Peter Staeheli; Thomas Decker; Mathias Müller; Birgit Strobl
Journal:  Mol Cell Biol       Date:  2014-04-07       Impact factor: 4.272

Review 8.  Mechanisms of Jak/STAT signaling in immunity and disease.

Authors:  Alejandro V Villarino; Yuka Kanno; John R Ferdinand; John J O'Shea
Journal:  J Immunol       Date:  2015-01-01       Impact factor: 5.422

Review 9.  Current prospects of type II interferon γ signaling and autoimmunity.

Authors:  Daniel S Green; Howard A Young; Julio C Valencia
Journal:  J Biol Chem       Date:  2017-06-26       Impact factor: 5.157

10.  Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.

Authors:  Isabella Rauch; Felix Rosebrock; Eva Hainzl; Susanne Heider; Andrea Majoros; Sebastian Wienerroither; Birgit Strobl; Silvia Stockinger; Lukas Kenner; Mathias Müller; Thomas Decker
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.